Aaron Brinkworth

Mr Brinkworth had a 22 year career with Gilead Sciences, Inc. (Gilead) during which time he held senior commercial, patient access and strategic licensing roles, including that of Executive Director Global Patient Solutions, where he was responsible for commercial and access strategies for emerging markets. He led Gileads commercial and access operations in the Asia Pacific (APAC) where he managed a geographically dispersed team and partners across 31 APAC countries. Currently serves as non executive Director for Proteomics International Laboratories Ltd , non executive Director for Atherid Therapeutics Pty Ltd and non-executive Director for Lixa Ltd. He is a graduate of the AICD Company Directors course and maintains active membership of the AICD.